A multi-disciplinary leader, Kelly Frankenreider is dedicated to advancing the global pharma strategy of Genentech’s parent company, the Roche Group, and ensuring the successful commercialization of a diverse product portfolio. She collaborates with various stakeholders across healthcare to prioritize the needs of patients and customers and plays a critical role in driving the evolution of Genentech’s business practices to keep pace with the rapidly changing field. As an influential leader within her organization, Frankenreider is responsible for triangulating US healthcare customer, data and digital insights with global strategies to achieve outcomes for all patients.

Since joining Genentech in 2006, Frankenreider has held a range of positions in marketing and customer engagement and has taken on increasingly complex leadership responsibilities. In her prior role as a healthcare executive director, she demonstrated her strategic expertise by building and leading a diverse and accountable team whose work was vital to advancing patient care. During her time in marketing, Frankenreider has led several commercial teams in Genentech’s diverse therapeutic areas and was instrumental in the strategy development and implementation of critical initiatives such as product launches, line extensions and overall portfolio management.

With more than 23 years of industry experience, Frankenreider began her career at Johnson & Johnson’s Ortho Biotech Oncology. During her time there, she held various sales and commercial training and development roles, honing her skills and knowledge in US healthcare.

Frankenreider holds a Bachelor of Science degree in biochemistry from North Central College in Naperville, Illinois.